5308-25-8 | 1-Ethylpiperazine

Packsize	Purity	Availability	Price	Discounted Price
25g	98%	in stock	$25.00	$18.00
100g	98%	in stock	$51.00	$36.00
500g	98%	in stock	$137.00	$96.00

Description

• Catalog Number: AB43342
• Chemical Name: 1-Ethylpiperazine
• CAS Number: 5308-25-8
• Molecular Formula: C6H14N2
• Molecular Weight: 114.1888
• MDL Number: MFCD00059912
• SMILES: CCN1CCNCC1
• NSC Number: 60707

Computed Properties

• Complexity: 57.5
• Covalently-Bonded Unit Count: 1
• Heavy Atom Count: 8
• Hydrogen Bond Acceptor Count: 2
• Hydrogen Bond Donor Count: 1
• Rotatable Bond Count: 1

Literature

• Synthesis, design and biological evaluation of novel highly potent tacrine congeners for the treatment of Alzheimer's disease.

  European journal of medicinal chemistry 20120901

• Radical pathway in catecholase activity with zinc-based model complexes of compartmental ligands.

  Inorganic chemistry 20120820

• 3-(Adamantan-1-yl)-1-[(4-ethyl-piperazin-1-yl)meth-yl]-4-[(E)-(4-hy-droxy-benzyl-idene)amino]-1H-1,2,4-triazole-5(4H)-thione.

  Acta crystallographica. Section E, Structure reports online 20120301

• Synthesis and biological evaluation of some thiazolidinones as antimicrobial agents.

  European journal of medicinal chemistry 20120201

• N-(4-Chloro-phen-yl)-4-ethyl-piperazine-1-carboxamide.

  Acta crystallographica. Section E, Structure reports online 20111001

• The phosphodiesterase-5 inhibitor vardenafil is a potent inhibitor of ABCB1/P-glycoprotein transporter.

  PloS one 20110101

• (S)-3-Chloro-4-(4-ethyl-piperazin-1-yl)-5-[(1R,2S,5R)-2-isopropyl-5-methyl-cyclo-hex-yloxy]furan-2(5H)-one.

  Acta crystallographica. Section E, Structure reports online 20100801

• Binary complexes of tertiary amines with phenylacetylene. Dispersion wins over electrostatics.

  Physical chemistry chemical physics : PCCP 20100621

• Synthesis and biological evaluation of nitrogen-containing chalcones as possible anti-inflammatory and antioxidant agents.

  Bioorganic & medicinal chemistry letters 20100115

• Catechol oxidase activity of a series of new dinuclear copper(II) complexes with 3,5-DTBC and TCC as substrates: syntheses, X-ray crystal structures, spectroscopic characterization of the adducts and kinetic studies.

  Inorganic chemistry 20080818

• Copper(I) cyanide networks: synthesis, structure, and luminescence behavior. Part 2. Piperazine ligands and hexamethylenetetramine.

  Inorganic chemistry 20080804

• Synthesis and biological activity of functionalized indole-2-carboxylates, triazino- and pyridazino-indoles.

  Archiv der Pharmazie 20080501

• Structure elucidation of a novel synthetic thiono analogue of sildenafil detected in an alleged herbal aphrodisiac.

  Journal of pharmaceutical and biomedical analysis 20080313

• Identification of a novel vardenafil analogue in herbal product.

  Journal of pharmaceutical and biomedical analysis 20080313

• Determination of analogs of sildenafil and vardenafil in foods by column liquid chromatography with a photodiode array detector, mass spectrometry, and nuclear magnetic resonance spectrometry.

  Journal of AOAC International 20080101

• Synthesis and Pharmacological Evaluation of (6-Substituted 4-Oxo-4H-chromene-3 yl) methyl N-substituted Aminoacetates.

  Indian journal of pharmaceutical sciences 20080101

• Structure determination of new analogues of vardenafil and sildenafil in dietary supplements.

  Food additives and contaminants 20070201

• Use of liquid chromatography-mass spectrometry and a hydrolytic technique for the detection and structure elucidation of a novel synthetic vardenafil designer drug added illegally to a 'natural' herbal dietary supplement.

  Journal of chromatography. A 20060825

• Patterns of metabolites produced from the fluoroquinolone enrofloxacin by basidiomycetes indigenous to agricultural sites.

  Applied microbiology and biotechnology 20060601

• Phenothiazine molecule provides the basic chemical structure for various classes of pharmacotherapeutic agents.

  American journal of therapeutics 20060101

• Carbonic anhydrase inhibitors: novel sulfonamides incorporating 1,3,5-triazine moieties as inhibitors of the cytosolic and tumour-associated carbonic anhydrase isozymes I, II and IX.

  Bioorganic & medicinal chemistry letters 20050615

• Structure determination of a sildenafil analogue contained in commercial herb drinks.

  Magnetic resonance in chemistry : MRC 20041201

• Structure elucidation of sildenafil analogues in herbal products.

  Food additives and contaminants 20040801